Eyestem Research Pvt Ltd, a pioneering biotechnology company developing advanced scalable cell therapy solutions for blindness caused by dry age-related macular degeneration, has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate the clinical trial of its










